TY - JOUR JF - INTERNATIONAL JOURNAL OF RECENTLY SCIENTIFIC RESEARCHER'S THEORY UR - https://uzindex.com/id/eprint/2523/ EP - 292 SN - 2992-8885 SP - 283 VL - 2 TI - TREATMENT OF PATISIRAN IN PATIENTS WHO HAS TRANSTHYRETIN CARDIAC AMYLOIDOSIS ID - uzindex2523 IS - 2 N2 -
Transthyretin amyloidosis, also called ATTR amyloidosis, is associated with accumulation of ATTR amyloid deposits in the heart and commonly manifests as progressive cardiomyopathy. Patisiran, an RNA interference therapeutic agent, inhibits the production of hepatic transthyretin
Y1 - 2024/02/01/ A1 - Haydarov, Abdulhamid ER -